Skip to content

US · NXGL · MEDICAL - INSTRUMENTS & SUPPLIES

NEXGEL, Inc. (NXGL) intrinsic value and stock valuation

$3.12as of 2026-11-21 · Mkt cap 3.48M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

NEXGEL, Inc. DCF and intrinsic value

InvestorsCraft values NXGL with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from NXGL’s statements →

NEXGEL, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Instruments & Supplies Langhorne, PA 19047 nexgel.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$11.4M+76.3% 5y CAGRd
20162025
Net income
-$-3M
20162025
Free cash flow
-$-1.38M
20162025
Total equity
$4.89M+133.8% 5y CAGRd
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$11.4M$8.69M$4.09M$2.05M$1.55M
Operating income-$-3.35M-$-3.55M-$-3.48M-$-3.35M-$-2.57M
Net income-$-3M-$-3.28M-$-3.16M-$-4.75M-$-4.31M
EPSd-$-382.17K-$-503.84K-$-557.32K-$-852.78K-$-773.79K
Operating cash flow-$-1.31M-$-3.87M-$-3.24M-$-2.99M-$-2.75M
Capital expenditure-$-70K-$-440K-$-700K-$-100K-$-270K
Free cash flow-$-1.38M-$-4.31M-$-3.93M-$-3.09M-$-3.02M
Total assets$10.5M$11M$9.96M$10.4M$17M
Total debt$3.09M$2.83M$2.8M$2.08M$4.26M
Net debt$2.77M$1.02M$100K$980K-$-9.09M
Total equity$4.89M$6.08M$5.17M$7.64M$12.1M
Cash and short-term investments$320K$1.81M$2.7M$6.61M$13.4M
Income statement
20252024202320222021
Revenue$11.4M$8.69M$4.09M$2.05M$1.55M
Cost of revenue$6.91M$5.94M$3.71M$1.79M$1.54M
Gross profit$4.51M$2.75M$370K$260K$10K
Research and development expenses$0.00$80K$100K$370K$30K
Selling, general and administrative expenses$7.86M$5.91M$3.4M$2.82M$2.4M
Other expenses$0.00$310K$350K$420K$140K
Operating expenses$7.86M$6.3M$3.85M$3.6M$2.58M
Cost and expenses$14.8M$12.2M$7.57M$5.4M$4.12M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$30K$80K$10K$1.34M$2M
Depreciation and amortization$740K$480K$440K$300K$140K
Ebitda-$-2.12M-$-2.9M-$-2.73M-$-3.11M-$-2.17M
Operating income-$-3.35M-$-3.55M-$-3.48M-$-3.35M-$-2.57M
Total other income/expenses, net$460K$90K$290K-$-1.4M-$-1.74M
Income before tax-$-2.89M-$-3.46M-$-3.19M-$-4.75M-$-4.31M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-3M-$-3.28M-$-3.16M-$-4.75M-$-4.31M
Weighted average shares outstanding$7.85M$6.51M$5.67M$5.57M$5.57M
Weighted average diluted shares outstanding$7.85M$6.51M$5.67M$5.57M$5.57M
Balance sheet
20252024202320222021
Cash and short-term investments$320K$1.81M$2.7M$6.61M$13.4M
Net receivables$670K$930K$630K$220K$210K
Inventory$2.11M$1.75M$1.32M$500K$290K
Total current assets$4.34M$5.11M$5.05M$7.5M$13.9M
Property, plant and equipment, net$3.97M$3.84M$3.35M$2.46M$2.65M
Goodwill and intangible assets$1.81M$1.94M$1.45M$330K$340K
Long-term investments$250K$0.00$0.00$0.00$0.00
Total non-current assets$6.12M$5.87M$4.9M$2.85M$3.06M
Total assets$10.5M$11M$9.96M$10.4M$17M
Accounts payable$1.29M$1.29M$1.23M$270K$250K
Short-term debt$470K$390K$560K$220K$2.25M
Deferred revenue$0.00$180K$20K$0.00$50K
Total current liabilities$2.96M$2.47M$2.55M$860K$2.89M
Long-term debt$2.61M$2.43M$2.24M$1.86M$2.01M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$2.61M$2.43M$2.24M$1.86M$2.01M
Capital lease obligations$2.5M$2.14M$1.96M$1.8M$1.95M
Total liabilities$5.57M$4.9M$4.79M$2.72M$4.9M
Common stock$10K$10K$10K$10K$10K
Retained earnings-$-21M-$-18M-$-14.71M-$-11.56M-$-6.81M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$4.89M$6.08M$5.17M$7.64M$12.1M
Total investments$250K$0.00$0.00$5.51M$0.00
Total debt$3.09M$2.83M$2.8M$2.08M$4.26M
Net debt$2.77M$1.02M$100K$980K-$-9.09M
Cash flow statement
20252024202320222021
Net income-$-2.89M-$-3.28M-$-3.16M-$-4.75M-$-4.31M
Depreciation and amortization$740K$480K$440K$300K$110K
Stock-based compensation$650K$370K$220K$300K$280K
Change in working capital$470K-$-1.17M-$-420K-$-230K-$-590K
Accounts receivable$260K-$-300K-$-410K-$-10K-$-140K
Inventory-$-360K-$-430K-$-760K-$-210K-$-60K
Accounts payable-$0.00$180K$970K$10K-$-410K
Net cash provided by operating activities-$-1.31M-$-3.87M-$-3.24M-$-2.99M-$-2.75M
Investments in property, plant and equipment-$-70K-$-440K-$-700K-$-100K-$-270K
Acquisitions, net$0.00-$-400K-$-550K$100K$0.00
Net cash used for investing activities-$-70K-$-780K$4.46M-$-5.59M-$-270K
Common stock issued$960K$3.77M$0.00$0.00$13.5M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$630K$3.75M$380K-$-3.66M$16.3M
Net change in cash-$-750K-$-890K$1.6M-$-12.25M$13.3M
Cash at end of period$1.06M$1.81M$2.7M$1.1M$13.4M
Operating cash flow-$-1.31M-$-3.87M-$-3.24M-$-2.99M-$-2.75M
Capital expenditure-$-70K-$-440K-$-700K-$-100K-$-270K
Free cash flow-$-1.38M-$-4.31M-$-3.93M-$-3.09M-$-3.02M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About NEXGEL, Inc.

        NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.

        CEO
        Adam R. Levy
        Employees
        19
        Beta
        0.76

        Explore

        Frequently asked questions

        What is the intrinsic value of NEXGEL, Inc. (NXGL)?

        InvestorsCraft does not currently publish an intrinsic value for NXGL. How the IC value is calculated.

        Is NXGL undervalued?

        InvestorsCraft does not publish an undervaluation signal for NXGL at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.